p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics

[1]  R. Reis,et al.  Frequency of KRAS p.Gly12Cys Mutation in Brazilian Patients With Lung Cancer , 2021, JCO global oncology.

[2]  Chuantao Zhang,et al.  Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer , 2021, Scientific Reports.

[3]  P. Jänne,et al.  KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Advanced/ Metastatic Non–Small-Cell Lung Cancer (NSCLC) Harboring KRAS G12C Mutation , 2020 .

[4]  J. Desai,et al.  KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors. , 2020, The New England journal of medicine.

[5]  M. Meyerson,et al.  Genetic ancestry contributes to somatic mutations in lung cancers from admixed Latin American populations , 2020, medRxiv.

[6]  Edward S. Kim,et al.  Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC). , 2020 .

[7]  A. Azmi,et al.  KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne? , 2020, Cancer treatment reviews.

[8]  J. Desai,et al.  The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity , 2019, Nature.

[9]  W. Hwang,et al.  Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non-Small-Cell Lung Cancer. , 2019, JCO precision oncology.

[10]  L. Moens,et al.  Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11. , 2019, Lung cancer.

[11]  R. Reis,et al.  Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations , 2019, Scientific Reports.

[12]  M. Socorro,et al.  Nuevos datos estadísticos genético-poblacionales para microsatélites en Colombia , 2019 .

[13]  D. Balding,et al.  Latin Americans show wide-spread Converso ancestry and imprint of local Native ancestry on physical appearance , 2018, Nature Communications.

[14]  M. Schabath,et al.  Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  M. Ladanyi,et al.  Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non–Small Cell Lung Cancer , 2017, Clinical Cancer Research.

[16]  J. Mazières,et al.  Molecular biomarkers for lung adenocarcinoma , 2017, European Respiratory Journal.

[17]  Jo-Anne Bright,et al.  Population data on the expanded CODIS core STR loci for eleven populations of significance for forensic DNA analyses in the United States. , 2016, Forensic science international. Genetics.

[18]  Yu Shyr,et al.  Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade , 2016, Cancer Immunology Research.

[19]  Matthew Meyerson,et al.  Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP) , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  Shingo Matsumoto,et al.  Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer. , 2015, Translational lung cancer research.

[21]  I. Louro,et al.  New CODIS core loci allele frequencies for 96,400 Brazilian individuals. , 2014, Forensic science international. Genetics.

[22]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[23]  Yi-long Wu,et al.  Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap) , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  M. Ladanyi,et al.  Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas , 2013, Cancer.

[25]  Seungbok Lee,et al.  A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. , 2012, Genome research.

[26]  Susanna M Cramb,et al.  The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  S. Rodenhuis,et al.  Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. , 1987, The New England journal of medicine.

[28]  John M. Butler,et al.  STRBase: a short tandem repeat DNA database for the human identity testing community , 2001, Nucleic Acids Res..